Literature DB >> 24237328

Spray drying formulation of albendazole microspheres by experimental design. In vitro-in vivo studies.

Agustina García1, Darío Leonardi, Gisela N Piccirilli, María E Mamprin, Alejandro C Olivieri, María C Lamas.   

Abstract

Both an experimental design and optimization techniques were carried out for the development of chitosan-pectin-carboxymethylcellulose microspheres to improve the oral absorption of albendazole as a model drug. The effect of three different factors (chitosan, pectin and carboxy methyl cellulose concentrations) was studied on five responses: yield, morphology, dissolution rate at 30 and 60 min, and encapsulation efficiency of the microspheres. During the screening phase, the factors were evaluated in order to identify those which exert a significant effect. Simultaneous multiple response optimizations were then used to find out experimental conditions where the system shows the most adequate results. The optimal conditions were found to be: chitosan concentration, 1.00% w/v, pectin concentration 0.10% w/v and carboxymethylcellulose concentration 0.20% w/v. The bioavailability of the loaded drug in the optimized microspheres was evaluated in Wistar rats which showed an area under curve (AUC) almost 10 times higher than the pure drug.

Entities:  

Keywords:  Albendazole; biomaterials; microspheres; oral drug release; spray drying

Mesh:

Substances:

Year:  2013        PMID: 24237328     DOI: 10.3109/03639045.2013.858737

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  Synthesis and characterization of a new cyclodextrin derivative with improved properties to design oral dosage forms.

Authors:  Agustina García; Josefina Priotti; Ana Victoria Codina; María Delia Vasconi; Ariel D Quiroga; Lucila I Hinrichsen; Dario Leonardi; María Celina Lamas
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

2.  Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate.

Authors:  María Esperanza Adrover; Marisa Pedernera; Magali Bonne; Bénédicte Lebeau; Verónica Bucalá; Loreana Gallo
Journal:  Saudi Pharm J       Date:  2019-11-13       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.